The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for BC Group International sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
BC Group International is a medical device company that develops, manufactures and supplies biomedical test equipment and measurement equipment. The company’s products include defibrillator analyzers, electrical safety analyzers, electrosurgical analyzers, infusion device analyzers, NIBP simulators, patient simulators, pulse oximetry simulators, standard and high accuracy digital pressure meters. BC Group also offers equipment repair services. The company serves test equipment needs of the biomedical engineering community. It markets its products in the US and abroad. BC Group is headquartered in Saint Charles, Missouri, the US
The key metrics of BC Group International related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As BC Group International is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as BC Group International.
For a detailed understanding of the performance of BC Group International, buy the report here.